Hemojuvelin
Hemojuvelin (also known as HJV, RGMc or HFE2) is a protein that in humans is encoded by the HFE2 gene. Hemojuvelin is a key regulator of systemic iron homeostasis, and mutations in the HFE2 gene can lead to juvenile hemochromatosis, a severe iron overload disorder.
Function[edit | edit source]
Hemojuvelin is a glycosylphosphatidylinositol-anchored protein that is involved in the regulation of systemic iron homeostasis. It acts as a bone morphogenetic protein (BMP) co-receptor, enhancing the efficiency of BMP binding to its receptor. This interaction leads to the activation of SMAD proteins, which regulate the expression of hepcidin, a hormone that is the main regulator of systemic iron homeostasis.
Clinical significance[edit | edit source]
Mutations in the HFE2 gene are associated with juvenile hemochromatosis, a severe iron overload disorder characterized by the early onset of endocrine and cardiac abnormalities. The disorder is inherited in an autosomal recessive manner.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
Hemojuvelin Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD